Results showed that DR-TB patients still display a high plasma level of IFNγ and IL-12 at 6 m of anti-TB therapy, whereas DS-TB patients showed a decrease in these cytokine levels (Fig. 5B and C, respectively). This evidence concerns the gene IFNG and tuberculosis.